Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Spinocerebellar Degenerations × E7046 × Thoracic × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Gynecologic 1 Gastrointestinal 1 Breast 1

Conditions

Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Spinocerebellar Degenerations 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

spartalizumab 1 pembrolizumab 1 E7046 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04432857 2024-06-27

AN0025 and Pembrolizumab Combination in Advanced Solid Tumors

Adlai Nortye Biopharma Co., Ltd.

Phase 1 Active not recruiting

BreastGastrointestinalGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Spinocerebellar Degenerations, Colorectal Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡